Achalasia Cardia Unmasking 4A Syndrome in an Adolescent
Case Reports in Gastrointestinal Medicine · 2026-01 · 2026 (1)
DOI: 10.1155/crgm/2759705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Gastrointestinal Medicine, online erschienen am 20.11.2026. Verfasst von Abinash Mishra und 4 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Achalasia cardia is an esophageal motility disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent peristalsis, leading to progressive dysphagia and weight loss. Often isolated, achalasia can occur as part of rare syndromes such as 4A Syndrome, which includes achalasia, Addison’s disease (adrenocorticotropic hormone [ACTH]–resistant adrenal insufficiency), alacrima, and autonomic dysfunction. Case Presentation A 15‐year‐old male presented with 1.5 years of progressive dysphagia, initially affecting liquids and later solids, along with retrosternal chest pain, regurgitation, and 6 kg weight loss. He had a history of recurrent dry eyes since birth and symptoms of fatigue, dizziness, and skin darkening over the past 2 years. Examination revealed diffuse hyperpigmentation, dry eyes, hyperemic conjunctivae, and bilateral weakness of ankle dorsiflexion with diminished ankle jerk. His BMI was 17.53 kg/m 2 , indicating undernutrition. Diagnostic Workup Esophagogastroduodenoscopy (EGD) raised clinical suspicion of achalasia cardia, demonstrating a dilated esophagus and a tight gastroesophageal junction; high‐resolution manometry (HRM) confirmed the diagnosis. Corticosteroid and ACTH tests indicated ACTH‐resistant adrenal insufficiency (Addison’s disease). Schirmer’s test confirmed alacrima. Genetic testing revealed mutations in the AAAS gene, confirming 4A Syndrome. Nerve conduction studies showed motor axonal neuropathy. Treatment and Outcome Pneumatic dilation with 30 and 35 mm balloons resulted in a reduction of the Eckardt score from 7 to 2. Hydrocortisone therapy (10 mg morning, 5 mg evening) improved skin manifestations and weakness. The patient gained 3 kg in weight over 6 months, indicating clinical improvement.
Conclusion
This case highlights the rare co‐occurrence of achalasia cardia, ACTH‐resistant adrenal insufficiency, alacrimia, and peripheral neuropathy in 4A Syndrome. Early diagnosis and a multidisciplinary treatment approach led to significant improvement, making this the first reported case of 4A Syndrome in India.
Zitieren
APA
Mishra, A., Parida, P. K., Mohapatra, R. K. D., Dash, K. R., & Das, H. S. (2026). Achalasia Cardia Unmasking 4A Syndrome in an Adolescent. Case Reports in Gastrointestinal Medicine, 2026(1). https://doi.org/10.1155/crgm/2759705
Vancouver
Mishra A, Parida PK, Mohapatra RKD, Dash KR, Das HS. Achalasia Cardia Unmasking 4A Syndrome in an Adolescent. Case Reports in Gastrointestinal Medicine. 2026;2026(1). doi:10.1155/crgm/2759705
BibTeX
@article{Mishra2026,
author = {Mishra, Abinash and Parida, Prasanta Kumar and Mohapatra, Ritik Kumar Das and Dash, Kaibalya Ranjan and Das, Haribhakti Seba},
title = {Achalasia Cardia Unmasking 4A Syndrome in an Adolescent},
journal = {Case Reports in Gastrointestinal Medicine},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crgm/2759705}
}
EUVIMED